HEADER LIGASE 21-OCT-05 2C4P TITLE CRYSTAL STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME UBCH5A COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN-CONJUGATING ENZYME E2 D1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: UBIQUITIN-PROTEIN LIGASE D1, UBIQUITIN CARRIER PROTEIN D1, COMPND 5 UBCH5, UBIQUITIN-CONJUGATING ENZYME E2-17KDA, UBCH5A; COMPND 6 EC: 6.3.2.19; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET VECTOR; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PETM-12 (EMBL) KEYWDS THIOESTERIFICATION, UBIQUITIN-CONJUGATING ENZYME, LIGASE, UBL KEYWDS 2 CONJUGATION PATHWAY EXPDTA X-RAY DIFFRACTION AUTHOR R.B.DODD,R.J.READ REVDAT 3 13-DEC-23 2C4P 1 REMARK REVDAT 2 24-FEB-09 2C4P 1 VERSN REVDAT 1 22-NOV-06 2C4P 0 JRNL AUTH R.B.DODD,R.J.READ JRNL TITL STRUCTURES OF TWO HUMAN UBIQUITIN-CONJUGATING ENZYMES FROM JRNL TITL 2 TWINNED CRYSTALS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1012047.880 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 11589 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.400 REMARK 3 FREE R VALUE TEST SET COUNT : 878 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.012 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.51 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.31 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1228 REMARK 3 BIN R VALUE (WORKING SET) : 0.3350 REMARK 3 BIN FREE R VALUE : 0.4080 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 87 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.043 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2343 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 115 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.05000 REMARK 3 B22 (A**2) : 1.29000 REMARK 3 B33 (A**2) : 3.76000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.51 REMARK 3 ESD FROM SIGMAA (A) : 0.69 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.64 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.82 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.371 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.140 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.010 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.300 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.070 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL USED REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 76.01 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DUE TO THE PRESENCE OF ORTHORHOMBIC REMARK 3 PSEUDOSYMMETRY, THE TEST SET OF REFLECTIONS WERE CHOSEN IN REMARK 3 P212121 AND THEN EXPANDED TO COVER THE MONOCLINIC SPACE GROUP. REMARK 3 DATA WERE FOUND TO BE NEAR- PERFECTLY TWINNED AND WERE THEREFORE REMARK 3 TREATED AS PERFECTLY TWINNED. NCS RESTRAINTS WERE APPLIED DURING REMARK 3 REFINEMENT WITH POSITIONAL RESTRAINTS OF 30 KCAL/MOL-A**2 (300 REMARK 3 INITIALLY) AND B-FACTOR TARGET SIGMA OF 2 REMARK 4 REMARK 4 2C4P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1290025957. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-04 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9821 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 89448 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 30.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.47 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1QCQ REMARK 200 REMARK 200 REMARK: DATA WERE INITIALLY SOLVED IN P1 TO ALLOW DISTINCTION REMARK 200 BETWEEN CRYSTALLOGRAPHIC AND PSEUDOSYMMETRY AXES TO BE MADE REMARK 200 PRIOR TO PROCESSING IN P21. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM AMMONIUM SULPHATE, 100 MM REMARK 280 SODIUM ACETATE TRIHYDRATE [PH 4.6], 25% W/V PEG MME 2000, PH 4.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.28250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYZES THE COVALENT ATTACHMENT OF UBIQUITIN TO OTHER REMARK 400 PROTEINS. MEDIATES THE SELECTIVE DEGRADATION OF SHORT-LIVED REMARK 400 AND ABNORMAL PROTEINS. FUNCTIONS IN THE E6/E6-AP-INDUCED REMARK 400 UBIQUITINATION OF P53/TP53. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -17 REMARK 465 LYS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 PRO A -9 REMARK 465 MET A -8 REMARK 465 SER A -7 REMARK 465 GLY A -6 REMARK 465 LEU A -5 REMARK 465 VAL A -4 REMARK 465 PRO A -3 REMARK 465 MET B -17 REMARK 465 LYS B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 PRO B -9 REMARK 465 MET B -8 REMARK 465 SER B -7 REMARK 465 GLY B -6 REMARK 465 LEU B -5 REMARK 465 VAL B -4 REMARK 465 PRO B -3 REMARK 465 ARG B -2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 8 CG CD CE NZ REMARK 470 GLN A 14 CG CD OE1 NE2 REMARK 470 LYS B 63 CG CD CE NZ REMARK 470 ARG B 90 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 132 CG CD OE1 OE2 REMARK 470 ARG B 136 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 18 C - N - CA ANGL. DEV. = 10.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 0 -0.70 -152.61 REMARK 500 ALA A 19 4.34 49.33 REMARK 500 PRO A 41 -34.42 -35.03 REMARK 500 ASN A 79 -168.36 -112.85 REMARK 500 ARG A 90 -44.14 -176.69 REMARK 500 ASN A 135 11.15 -69.83 REMARK 500 MET B 1 -71.56 -57.65 REMARK 500 ARG B 15 -36.36 174.60 REMARK 500 ALA B 19 7.22 54.68 REMARK 500 HIS B 20 -8.75 -142.83 REMARK 500 ASP B 28 48.11 -96.03 REMARK 500 THR B 58 3.67 -69.13 REMARK 500 ARG B 90 -26.83 -141.30 REMARK 500 ASP B 117 71.41 -119.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2001 DISTANCE = 7.06 ANGSTROMS REMARK 525 HOH A2010 DISTANCE = 8.08 ANGSTROMS REMARK 525 HOH A2031 DISTANCE = 6.28 ANGSTROMS REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES FOR WHICH INSUFFICIENT DENSITY WAS OBSERVED FOR REMARK 999 SIDECHAINS WERE TRUNCATED TO ALANINES. THE PROTEIN WAS REMARK 999 TAGGED WITH A HIS6-TAG THAT WAS NEVER CLEAVED FROM THE REMARK 999 PROTEIN. THEREFORE, IN ADDITION TO THE RGS SEQUENCE REMARK 999 PRECEDING THE UNIPROT UBCH5A SEQUENCE, THE FOLLOWING REMARK 999 RESIDUES WERE PRESENT IN THE STRUCTURE, BUT NOT LOCATED REMARK 999 IN THE ELECTRON DENSITY MAPS,PRESUMABLY DUE TO DISORDER: REMARK 999 MKHHHHHHPMSGLVP DBREF 2C4P A -17 0 PDB 2C4P 2C4P -17 0 DBREF 2C4P A 1 147 UNP P51668 UB2D1_HUMAN 1 147 DBREF 2C4P B -17 0 PDB 2C4P 2C4P -17 0 DBREF 2C4P B 1 147 UNP P51668 UB2D1_HUMAN 1 147 SEQRES 1 A 165 MET LYS HIS HIS HIS HIS HIS HIS PRO MET SER GLY LEU SEQRES 2 A 165 VAL PRO ARG GLY SER MET ALA LEU LYS ARG ILE GLN LYS SEQRES 3 A 165 GLU LEU SER ASP LEU GLN ARG ASP PRO PRO ALA HIS CYS SEQRES 4 A 165 SER ALA GLY PRO VAL GLY ASP ASP LEU PHE HIS TRP GLN SEQRES 5 A 165 ALA THR ILE MET GLY PRO PRO ASP SER ALA TYR GLN GLY SEQRES 6 A 165 GLY VAL PHE PHE LEU THR VAL HIS PHE PRO THR ASP TYR SEQRES 7 A 165 PRO PHE LYS PRO PRO LYS ILE ALA PHE THR THR LYS ILE SEQRES 8 A 165 TYR HIS PRO ASN ILE ASN SER ASN GLY SER ILE CYS LEU SEQRES 9 A 165 ASP ILE LEU ARG SER GLN TRP SER PRO ALA LEU THR VAL SEQRES 10 A 165 SER LYS VAL LEU LEU SER ILE CYS SER LEU LEU CYS ASP SEQRES 11 A 165 PRO ASN PRO ASP ASP PRO LEU VAL PRO ASP ILE ALA GLN SEQRES 12 A 165 ILE TYR LYS SER ASP LYS GLU LYS TYR ASN ARG HIS ALA SEQRES 13 A 165 ARG GLU TRP THR GLN LYS TYR ALA MET SEQRES 1 B 165 MET LYS HIS HIS HIS HIS HIS HIS PRO MET SER GLY LEU SEQRES 2 B 165 VAL PRO ARG GLY SER MET ALA LEU LYS ARG ILE GLN LYS SEQRES 3 B 165 GLU LEU SER ASP LEU GLN ARG ASP PRO PRO ALA HIS CYS SEQRES 4 B 165 SER ALA GLY PRO VAL GLY ASP ASP LEU PHE HIS TRP GLN SEQRES 5 B 165 ALA THR ILE MET GLY PRO PRO ASP SER ALA TYR GLN GLY SEQRES 6 B 165 GLY VAL PHE PHE LEU THR VAL HIS PHE PRO THR ASP TYR SEQRES 7 B 165 PRO PHE LYS PRO PRO LYS ILE ALA PHE THR THR LYS ILE SEQRES 8 B 165 TYR HIS PRO ASN ILE ASN SER ASN GLY SER ILE CYS LEU SEQRES 9 B 165 ASP ILE LEU ARG SER GLN TRP SER PRO ALA LEU THR VAL SEQRES 10 B 165 SER LYS VAL LEU LEU SER ILE CYS SER LEU LEU CYS ASP SEQRES 11 B 165 PRO ASN PRO ASP ASP PRO LEU VAL PRO ASP ILE ALA GLN SEQRES 12 B 165 ILE TYR LYS SER ASP LYS GLU LYS TYR ASN ARG HIS ALA SEQRES 13 B 165 ARG GLU TRP THR GLN LYS TYR ALA MET FORMUL 3 HOH *115(H2 O) HELIX 1 1 SER A 0 ASP A 12 1 13 HELIX 2 2 LEU A 86 ARG A 90 5 5 HELIX 3 3 THR A 98 ASP A 112 1 15 HELIX 4 4 VAL A 120 ASP A 130 1 11 HELIX 5 5 ASP A 130 ALA A 146 1 17 HELIX 6 6 GLY B -1 ASP B 12 1 14 HELIX 7 7 LEU B 86 SER B 91 1 6 HELIX 8 8 THR B 98 ASP B 112 1 15 HELIX 9 9 VAL B 120 ASP B 130 1 11 HELIX 10 10 ASP B 130 ALA B 146 1 17 SHEET 1 AA 4 CYS A 21 VAL A 26 0 SHEET 2 AA 4 ASP A 29 MET A 38 -1 N ASP A 29 O VAL A 26 SHEET 3 AA 4 VAL A 49 HIS A 55 -1 O PHE A 50 N ILE A 37 SHEET 4 AA 4 LYS A 66 PHE A 69 -1 O LYS A 66 N HIS A 55 SHEET 1 BA 4 ALA B 23 PRO B 25 0 SHEET 2 BA 4 HIS B 32 MET B 38 -1 O GLN B 34 N GLY B 24 SHEET 3 BA 4 VAL B 49 HIS B 55 -1 O PHE B 50 N ILE B 37 SHEET 4 BA 4 LYS B 66 PHE B 69 -1 O LYS B 66 N HIS B 55 CISPEP 1 TYR A 60 PRO A 61 0 -0.59 CISPEP 2 TYR B 60 PRO B 61 0 -0.54 CRYST1 45.621 50.565 66.043 90.00 90.00 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021920 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019777 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015142 0.00000 MTRIX1 1 0.996470 -0.083010 0.012240 -21.35963 1 MTRIX2 1 -0.083440 -0.995710 0.039940 83.07368 1 MTRIX3 1 0.008870 -0.040820 -0.999130 33.71801 1